Clinical-stage biopharmaceutical company
Appears in 1 story · Last updated Nov 15, 2026
Sponsor of the VENTURE and VANQUISH trials of VK2735
Seventy-four percent of people who took Viking Therapeutics' experimental obesity drug for 13 weeks dropped at least one body mass index class. Among those on placebo, 15% did.
Updated 3 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?